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CAPILLARY MICROSCOPY IN 
EOSINOPHILIC FASCIITIS 
A Comparison with Systemic Sclerosis 
MICHAEL B. ROZBORIL, HILDEGARD R. MARICQ, GERALD P. RODNAN, 
STEPHANIA JABLONSKA, and GILES G. BOLE 
Capillary microscopy was performed on 19 pa- 
tients with eoslnophilic fasciitis. These patients were 
compared with 13 individuals with progressive systemic 
sclerosis (scleroderma). Capillary patterns were normal 
in 16 of 19 (84%) eosinophilic fasciitis patients; 3 
exhibited either borderline or nonspecific changes, and 
none showed a definite scleroderma pattern. In con- 
trast, characteristic nailfold capillary changes, consist- 
ing of both dilatation and loss of capillaries, were 
present in 11 of 13 (85%) scleroderrna patients; the 
remaining 2 showed scleroderma-type abnormalities of 
only 1 finger and were, therefore, classified as border- 
line. These results suggest that capillary microscopy 
may help to distinguish these 2 disorders. 
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Using widefield capillary microscopy, a charac- 
teristic pattern of nailfold vascular changes has been 
found in progressive systemic sclerosis (scleroderma, 
PSS) (1-7). These changes consist of dilated, often 
distorted capillary loops, areas of capillary dropout, 
and loss of the orderly appearance of the capillary bed 
(8). This pattern has been noted in over 80% of PSS 
patients (6,9). Similar changes may be seen in several 
other rheumatic conditions such as dermatomyositis 
and mixed connective tissue disease (overlap syn- 
dromes), especially when a component of PSS is 
present, but the frequency is much lower than in PSS. 
Eosinophilic fasciitis (EF) is a recently recog- 
nized scleroderma-like disorder characterized by sym- 
metric, often widespread inflammation and sclerosis of 
the deep fascia, subcutis, and dermis, chiefly affecting 
the extremities; on occasion the face and trunk are 
involved as well. The disorder typically commences 
with pain and swelling of the forearms. hands, legs, 
and feet. This is followed by evident inflammation and 
induration of the skin and subcutaneous tissues of 
these parts; striking contractures may develop in a 
period as  short as  a few weeks (10-16). Abnormal 
laboratory findings include peripheral blood eosino- 
philia, hypergammaglobulinemia, and elevated sedi- 
mentation rate. A full thickness biopsy from skin to 
muscle is diagnostic with findings of thickened, scle- 
rotic dermis, subcutis, and fascia and infiltration with 
mononuclear cells, often with tissue eosinophils 
(12,13). Sclerodactyly, seen almost without exception 
in PSS, is often absent in EF; Raynaud’s phenomenon 
and visceral involvement are distinctly unusual 
(16.17). Prognosis has generally been good with many 
patients responding to corticosteroids during the early, 
Arthritis and Rheumatism, Vd. 26, No. 5 (May 1M3) 
618 ROZBORIL ET AL 
Figure 1. Normal nailfold capillary pattern. 
inflammatory stage; with time there is gradual resolu- 
tion of induration and contractures. 
Nailfold capillary changes have not been de- 
scribed in eosinophilic fasciitis. We performed nailfold 
capillary microscopy on 19 patients with EF to deter- 
mine what changes, if any, were present in individuals 
with this disorder. Since at first glance the appearance 
of EF resembles that of PSS, we hoped to determine 
whether capillary microscopy could help differentiate 
these 2 disorders and resolve controversy concerning 
the relationship, if any, between EF and PSS. 
PATIENTS AND METHODS 
Patients. Thirty-six patients were examined at the 
following medical centers: University of Michigan, Ann 
Arbor, 20 patients; University of Pittsburgh, 8 patients; 
Medical University of South Carolina, Charleston, 3 pa- 
tients; and Klinika Dermatologizcna, Warsaw, Poland, 5 
patients. They were divided into the following groups: 
eosinophilic fasciitis: 19, progressive systemic sclerosis: 13, 
normal controls: 4. 
The diagnosis of EF was made in all 19 patients by 
the presence of characteristic clinical findings in the skin and 
subcutaneous tissues, peripheral blood eosinophilia, and 
positive full thickness biopsies. Hypergammaglobulinemia 
and elevated sedimentation rates were variable and were not 
used as inclusion criteria. PSS was diagnosed by the pres- 
ence of typical sclerodermatous skin changes over the 
fingers (10 of 13) or proximal to the metacarpophalangeal 
joints (7 of 13), and by Raynaud’s phenomenon (13 of 13), 
digital pitting scars (3 of 13), and interstitial lung disease by 
radiographic examination or abnormal diffusing capacity of 
carbon monoxide (9 of 13). Four normal controls (personnel 
associated with the arthritis center, free of rheumatic dis- 
ease) were included to provide additional photographs of 
nailfold capillaries. These were mixed with the patients’ 
photographs to improve the accuracy of the “blind” analysis 
of coded photographs. Information on the range of normal 
variations of the nailfold capillary bed is available from 
previous studies (18). 
Technique. Observations and photography of the 
nailfold capillaries were performed using capillaroscopic 
technique as previously described (7,8). In addition to direct 
evaluation of patients by the authors (MBR, HRM, SJ), 
photographs of all patients examined at the Universities of 
Michigan and Pittsburgh (11 EF, 13 PSS, and 4 normal 
controls) were coded without diagnosis and sent to the 
second author (HRM) for “blind” evaluation and diagnostic 
interpretation. Eight digits from each patient were exam- 
ined; photographs of at least 2 digits from each patient (most 
often the ring or little fingers) were submitted for analysis. 
When difficulties in interpretation or borderline abnormali- 
ties were seen in isolated photographs, pictures of other 
digits from the same patient were examined. 
Findings were described as normal, definite sclero- 
derma (SD) pattern, borderline SD, or nonspecific. A normal 
pattern (Figure 1) contains a uniform arcade of thin, hairpin 
shaped capillary loops along the edge of the nailfold and an 
even distribution of proximal capillaries (4,8). Enlargement 
of capillary loops, loss of capillaries, and disruption of the 
orderly capillary bed characterize the “SD pattern,” so 
called because this group of abnormalities was observed in 
over 80% of progressive systemic sclerosis patients (8). As 
defined previously (8). at least 2 definitely enlarged capillar- 
ies per nailfold and at least 2 involved digits were necessary 
to place a patient in the “definitely abnormal” category 
(Figure 2). The borderline SD pattern included abnormalities 
confined to a single digit. A nonspecific pattern referred to 
findings such as increased tortuosity of vessels or increased 
variation in the caliber of otherwise normally shaped capil- 
lary loops (often more apparent in individuals with a promi- 
nent subpapillary plexus), changes that are not specific for 
PSS but represent deviations from a normal pattern (4,18). 
Complete photographic data from the 5 Polish pa- 
- 
Figure 2. Definite SD pattern with capillary dilatation and avascu- 
lar areas in a patient with systemic sclerosis. 
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Symptoms, months (range) 
Raynaud’s phenomenon 
Involvement of fingers 
Eosinophilia (>600/mm’) 
Hypergammaglobulinemia 
Elevated ESRt (>20 mmlhour) 
























* From onset of symptoms to time of capillary microscopy. 
t ESR = erythrocyte sedimentation rate. 
t ANA = antinuclear antibodies. 
tients with EF were not readily available; the evaluation of 
their capillary patterns was based on the reinterpretation of 
capillary observations reported from Warsaw, to conform 
with the capillary classification used for the patients in 
American medical centers. The capillary abnormalities seen 
in scleroderma and Raynaud’s disease have been divided 
into scleroderma loops and Raynaud’s loops (19,20) which 
roughly correspond to the SD pattern with and without 
capillary loss described by Maricq (8). 
RESULTS 
Selected clinical and laboratory findings are 
listed in Table 1. Mean age at time of capillary 
microscopy was similar in both groups. The frequency 
of Raynaud’s phenomenon was 0 in EF patients and 
100% in PSS patients. The time from disease onset to 
date of examination ranged from 1 month to 132 
months in patients with EF. At the time of capillary 
microscopy exam, 17 of 19 patients had clinically 
active disease, I had minimal cutaneous activity, and 1 
was in complete remission (the patient seen at 132 
months). Involvement of the skin of the fingers was 
Figure 3. Normal capillary pattern in a patient with eosinophilic 
fasciitis. 
Table 2. Nailfold capillary microscopic observations* 
seen in 7 of 19 (37%) patients with EF  and in 10 of 13 
(77%) PSS patients. Three of 13 PSS patients had 
proximal sclerodermatous skin changes only at the 
time of evaluation. Hypereosinophilia (as defined by 
maximum counts >600/mm3) was seen in 17 of 19 
patients with EF; 15 had counts >l,000/mm3, and 
peak values reached 4,200/mm3. The 2 other E F  pa- 
tients had counts of 494 and 598/mm3 respectively. 
Only 1 PSS patient had an eosinophil count measured, 
and this was normal. At the time of examination, 7 EF  
patients were taking corticosteriods, ranging from 7.5 
mg-40 mg/day; the other 12 were receiving no therapy. 
Results of capillary microscopy are presented 
in Table 2. Sixteen of the 19 patients with EF  had 
normal capillary patterns (Figure 3). Two patients 
were classified as borderline: 1 had engorged capillary 
loops that were thicker than normal with no decrease 
in the density of loops (Figure 4), the other, a patient in 
Poland, was reported to have Raynaud’s loops alone. 
Although he clearly had abnormal capillaries, there 
was not sufficient information available to classify him 
Abnormal?. 
Borderline 
Normal SD pattern SD pattern Nonspecific 
Eosinophilic 
Progressive systemic 
fasciitis (19) 16 (84%) - 2 ( 1  1%) I ( 5 % )  
sclerosis (13) - I I  (85%) 2 (15%) - 
Normal controls (4) 4 (100%) - - - 
* Number of patients (% of total). x2 = 18.66 (P < 0.001) (with Yates correction). 
t See text for explanation. 
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Figure 4. Borderline SD pattern with engorged capillaries but a 
normal density of loops. 
as having a definite SD pattern. It was therefore 
considered best to include him in the borderline group. 
The former patient was a manual laborer susceptible to 
digital trauma. Injury to the nailfold can lead to 
changes in the capillary bed that can be difficult to 
distinguish from the SD pattern when only a black and 
white photograph is examined; there may be focal 
engorgement of capillaries with associated microvas- 
cular hemorrhage that may further increase the appar- 
ent size of the capillary loops when the extravasation 
of red blood cells is confined within the pericapillary 
space. Direct observation of the fingers and nailfolds 
permits more accurate distinction between this injury 
pattern and the SD pattern. On “blind” evaluation of 
the photographs from this EF patient, the question of 
injury was raised, although by design of our blind 
evaluation system the final interpretation led to place- 
ment of the capillaries in the borderline SD pattern 
group. Both patients with borderline abnormalities 
were in the clinically active group, and neither was 
receiving therapy at  time of examination. 
One EF patient had a nonspecific abnormal 
pattern in which only 1 of her digits contained long, 
slightly enlarged capillaries with a prominent subpapil- 
lary venous plexus; the other digits were normal. This 
finding has been observed in a variety of diseases as 
well as in some normal individuals, and is not consid- 
ered specific (8). Of the 2 EF patients with borderline 
SD patterns, 1 had cutaneous involvement of the 
fingers and the other did not. Six other EF patients 
with changes in the fingers had normal capillaries. 
In contrast to the normal pattern seen in 16 of 
the 19 (84%) patients with EF, none of the 13 PSS 
patients had a normal capillary pattern. Eleven (85%) 
had a typical SD pattern while 2 others had a border- 
line SD pattern. These latter 2 patients each had 
capillary abnormalities involving only 1 digit; the other 
digits were normal. A chi-square analysis between 
normal and abnormal capillary microscopy findings in 
EF and PSS yielded a x2 (with Yates correction) of 
18.66 (P < 0.001). 
Results of the “blind” evaluation correlated 
well with our direct observations (Table 3). Nineteen 
of 22 digits from I 1  EF patients were read as normal, 2 
as borderline SD (both from the same patient), and 1 as 
nonspecific. Twenty-one digits from 13 PSS patients 
were definitely abnormal (SD pattern), 3 were border- 
line SD pattern, and only 2 digits were normal. One 
PSS patient had 1 borderline and 1 definitely abnormal 
digit; 2 others each had 1 borderline and 1 normal digit. 
In all the other PSS patients, both digits examined 
were abnormal. No abnormalities were found in 8 
digits from the 4 normal controls. 
Table 3. 
individuals studied* 
Results of the “blind” evaluation of nailfold capillary patterns in 56 digits from 28 
Abnormal 
Total no. Borderline 
of digits SD SD pat- Non- 
examined Normal pattern tern specific 
Eosinophilic 
2 1 fasciitis (1 I )  22 19 - 
Progressive systemic 
sclerosis (13) 26 2 21 3 - 
Normal controls (4) 8 8 - - - 
* Two digits from each individual were evaluated. 
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DISCUSSION 
This study demonstrates that nailfold capillaries 
are normal in the great majority of individuals with 
eosinophilic fasciitis. Minor abnormalities were seen 
in only 3 of 19 patients, with 2 of the 3 having a 
borderline SD pattern. This is in marked contrast to 
progressive systemic sclerosis, in which characteristic 
abnormalities generally occur. 
Sclerodactyly per se does not account for the 
nailfold capillary abnormalities seen in systemic scle- 
rosis. Two of our PSS patients without sclerodactyly 
(who had proximal sclerodermatous skin changes) had 
a definite SD pattern. An abnormal pattern has been 
seen in PSS patients with visceral disease only and no 
cutaneous changes (9). Six of our EF patients with 
involvement of the skin and subcutaneous tissue of 
their fingers had normal capillary patterns. 
Nor does the absence of Raynaud’s phenome- 
non account for the normal capillary findings in EF. 
Patients with Raynaud’s phenomenon alone have been 
shown to have normal capillaries, as have those with 
systemic lupus erythematosus with Raynaud’s phe- 
nomenon (6,7). In fact, the presence of capillary 
changes in individuals with Raynaud’s phenomenon is 
a strong predictor of progressive systemic sclerosis (6, 
21). Conversely, PSS patients and dermatomyositis 
patients without Raynaud’s phenomenon have exhibit- 
ed the typical SD pattern (although dermatomyositis 
may also manifest a “bushy” pattern that is more 
frequently seen in dermatomyositis than in PSS, but is 
not invariably present) (7,22). 
Some authors have suggested that EF is a 
variant in the clinical spectrum of progressive system- 
ic sclerosis, rather than a distinct disease entity (23- 
27). Although the etiology of both EF and PSS is 
unknown, microcirculation is a key factor in the 
pathologic changes that develop in PSS (28). A strong 
positive correlation has been found between multisys- 
tem involvement in PSS and the severity of the capil- 
lary pattern abnormality (9). Electron microscopic 
studies of scleroderma muscle capillaries have re- 
vealed thickening of the basement membrane, a de- 
crease in the number of capillaries, and the predom- 
inance of large capillaries with increased mean blood 
vessel diameter (29). Other vascular abnormalities, 
such as Raynaud’s phenomenon and nailfold capillary 
changes, are an integral feature of PSS. These abnor- 
malities are strikingly lacking in EF, and suggest 
different underlying processes. 
The results of this study suggest that capillary 
microscopy may be helpful in differentiating eosino- 
philic fasciitis from progressive systemic sclerosis, 
and support the theory that eosinophilic fasciitis is a 
separate disease entity and not a “forme fruste” or 
subset of systemic sclerosis. 
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